Reference Source

Ajanta Pharma Limited · 66-41 · INDIA

For Ajanta Pharma Limited · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product code is 65 P D - 02 Sildenafil Citrate (Regulator), Human - Rx/Combination Ingredient; date published is 09/30/2009; address is 318 Linking Road , Mumbai, INDIA, verified against its source on 2026-09-16.

Firm
Ajanta Pharma Limited verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
INDIA verified
Address
318 Linking Road , Mumbai, INDIA verified
Date published
09/30/2009 verified
Product code
65 P D - 02 Sildenafil Citrate (Regulator), Human - Rx/Combination Ingredient verified
FDA notes
Kamagra 100mg oral tablet; 4/4/2003 verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Ajanta Pharma Limited Date Published : 09/30/2009 318 Linking Road , Mumbai, INDIA 65 P D - 02 Sildenafil Citrate (Regulator), Human - Rx/Combination Ingredient Date Published: 09/13/2019 Notes: Kamagra 100mg oral tablet; 4/4/2003

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.